- Home
- NRT vs OSTX Comparison
NRT vs OSTX Comparison
Compare NRT & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- OSTX
- Stock Information
- Founded
- NRT 1975
- OSTX 2018
- Country
- NRT United States
- OSTX United States
- Employees
- NRT N/A
- OSTX N/A
- Industry
- NRT Oil & Gas Production
- OSTX
- Sector
- NRT Energy
- OSTX
- Exchange
- NRT Nasdaq
- OSTX NYSE
- Market Cap
- NRT 44.0M
- OSTX 36.2M
- IPO Year
- NRT N/A
- OSTX 2024
- Fundamental
- Price
- NRT $4.28
- OSTX $1.60
- Analyst Decision
- NRT
- OSTX Strong Buy
- Analyst Count
- NRT 0
- OSTX 2
- Target Price
- NRT N/A
- OSTX $17.50
- AVG Volume (30 Days)
- NRT 26.2K
- OSTX 2.2M
- Earning Date
- NRT 02-28-2025
- OSTX 03-25-2025
- Dividend Yield
- NRT 11.14%
- OSTX N/A
- EPS Growth
- NRT N/A
- OSTX N/A
- EPS
- NRT 0.56
- OSTX N/A
- Revenue
- NRT $5,942,748.00
- OSTX N/A
- Revenue This Year
- NRT N/A
- OSTX N/A
- Revenue Next Year
- NRT N/A
- OSTX $26,663.99
- P/E Ratio
- NRT $7.60
- OSTX N/A
- Revenue Growth
- NRT N/A
- OSTX N/A
- 52 Week Low
- NRT $3.88
- OSTX $1.41
- 52 Week High
- NRT $8.62
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- NRT 41.99
- OSTX N/A
- Support Level
- NRT $4.16
- OSTX N/A
- Resistance Level
- NRT $4.46
- OSTX N/A
- Average True Range (ATR)
- NRT 0.20
- OSTX 0.00
- MACD
- NRT -0.03
- OSTX 0.00
- Stochastic Oscillator
- NRT 24.00
- OSTX 0.00
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the significant need for new treatments in cancers of the bone in children and young adults.